Centiva Capital’s CureVac CVAC Stock Holding History

Centiva Capital’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-4,315	Closed	-$234K	–	1265
2021 Q3	$234K	Buy	4,315 +29	+0.7%	+$1.75K	0.01%	874
2021 Q2	$315K	Buy	+4,286	New	+$428K	0.01%	1024

Other funds holding CVAC

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Centiva Capital's CVAC Position: Q4 2021 in Review

Centiva Capital sold out of CureVac (CVAC) in Q4 2021, closing a stake of 4,315 shares — an estimated $234K sold.

Centiva Capital first reported a position in CVAC in Q2 2021 and held it in 2 quarters. The position peaked at $315K in Q2 2021. 104 funds tracked by Wall St. Rank hold CVAC as of Q4 2021.

Centiva Capital reported no remaining CureVac position as of Q4 2021 after selling out during the quarter.
Centiva Capital sold 4,315 CureVac shares in Q4 2021, an estimated $234K.
Centiva Capital first reported a position in CureVac in Q2 2021 and held it in 2 quarters.
Centiva Capital's CureVac position peaked at $315K in Q2 2021.
104 funds tracked by Wall St. Rank held CureVac as of Q4 2021.

Based on Centiva Capital's 13F filing for Q4 2021, filed 14 Feb 2022.